OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
March 19, 2021
A well-oiled, data-driven hub program is critical for stakeholders in supporting patients—and clearing a successful path for specialty therapies
Catchphrase or not, the patient journey is seemingly more complex than ever these days—upping the ante for new strategies in specialty-care support
2020 was a difficult year for many patients, but new data may signal a brighter future ahead
March 18, 2021
A conversation with Cathy Traz, global advocacy head at Bristol Myers Squibb
Non-commercial pharmacies can be secret weapons for intake and adherence
Their promise is prompting pharma leaders to give their hub/PAP CRM platforms a closer look
The key trends and considerations for specialty providers navigating a changing policy landscape
More leverage for community-based pharmacies and rules changes for drug-pricing reporting
Case study on closing the gap between new specialty drugs and specialty pharmacies